Competence Network for Congenital Heart Defects Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00266162
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

bosentan (tracleer) (1 trial)

Drugs in Phase 3 Trials (2)

dobutamine (dobutrex) (1 trial)

sildenafil (viagra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eisenmenger Complex (Phase 4)

Familial Primary Pulmonary Hypertension (Phase 3)

Hypertension (Phase 4)

Syndrome (Phase 4)

Tetralogy of Fallot (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3